There is no international diagnostic agreement for gestational diabetes mellitus (GDM). In 2014, Australia adopted a new definition and testing procedure.
| INTRODUC TI ON
Gestational diabetes mellitus (GDM) is a health condition diagnosed in pregnancy and associated with an increased risk of physical complications for the mother (eg caesarean section, pre-eclampsia) and infant (eg macrosomia, shoulder dystocia). 1 Women diagnosed with GDM have reported emotional and financial consequences such as self-blame and guilt, 2,3 confusion over diet management 4 and the expense of healthy eating. 5 Other women reported the diagnosis as an opportunity to change their behaviours. 6 The definition of GDM has a complex history. Definitions have used different theoretical premises (percentile range like most laboratory tests, the same values as in the non-pregnant or risk based).
Where a risk-based assessment has been used, over time the focus has shifted. For example, in 1964, O'Sullivan and Mahan 7 originally defined it as a way of identifying those women at risk of developing type 2 diabetes, whereas a large international study known as the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study 1 in 2008 focused on foetal outcomes. In addition, the diagnostic test has varied 8 from a 50 g glucose load 1-hour screening test, a 75 g 2-hour test and a 100 g 3-hour test. Recommendations were initially for screening only 'high-risk' pregnant women, but now include all women and diagnostic cut-points have varied over several decades. 9 The varying cut-points arise because the risk of complications of gestational diabetes is on a continuum. The higher the mother's blood glucose level (BGL), the higher the risk of complications to her and her baby. The HAPO study 1 aimed to find a cut-point in the continuum to guide decisions on where the BGL should be drawn to define GDM. Unfortunately, an obvious cut-point was not identified.
Using the available HAPO data, the International Association of the Diabetes and Pregnancy Study Groups (IADSPG) consensus panel recommended a BGL threshold associated with the risk of adverse infant outcomes (such as risk of macrosomia, excess infant adiposity and neonatal hyperinsulinaemia). 8 However, this change was controversial, and there is a lack of international consensus about the appropriate threshold between normal and elevated blood glucose.
Two recent Australian studies 10, 11 compared the old GDM definition and testing regimen to the new. Sexton and colleagues 10 in North Queensland reported an increase in GDM diagnoses from 10% under the old GDM definition to 20% under the new definition and Cade et al 11 in Melbourne from 6% to 10%. Despite significant increases in the number of women diagnosed with gestational diabetes, both studies reported negligible health benefits for mothers and babies. The Cade study 11 also reported a substantial increase in health-care costs: a net cost increase for their hospital alone was over A$560,000 annually. Importantly, many (but not all, eg the Royal Australian College of General Practitioners) medical colleges in Australia adopted the IADSPG new threshold and testing regimen.
Given the absence of consensus and the substantial increase in GDM diagnoses, we believe it is timely to explore the values and preferences of the women who may be directly impacted by the change in GDM diagnosis.
We conducted a citizen/community jury (CJ) to explore women's perspectives. A CJ is a form of deliberative democracy and aims to elicit an informed community perspective on important and often controversial topics. CJ participants are provided with expert presentations and opportunities to question the experts, engage in both facilitated and private deliberation and are asked to form a consensus or majority 'verdict' on the topic question. Community jury participants deliberate on questions requiring a decision that is both informed and ethically sensitive. CJs have been used successfully in research to elicit informed perspectives for several health policy issues, for example screening mammography, 12 screening for prostate cancer, 13 case finding for dementia, 14 quantifying health preferences 15 and more broadly in local governments. 16, 17 We asked the CJ participants to deliberate on two questions: 
| ME THOD

| Steering committee
We established a steering committee to plan both the community jury and a consensus panel meeting to discuss the definition of GDM in Australia. The steering committee included a general practitioner, two endocrinologists, a consumer representative and two researchers with CJ and qualitative experience. This committee determined the eligibility criteria of the CJ participants, drafted the CJ questions and considered the expert information necessary for the jurors to make recommendations.
| Participants
We recruited women from the Gold Coast region (Australia) and rural areas (identified via the Modified Monash Model 18 ) within driving distance to the Gold Coast through Taverner Research, using social media advertisements and random generated landline and location sample drawn from SamplePages. CJ participants are sampled from the public most directly affected by the deliberation question; therefore, 15 women between age 30 and 45 years (median age of mothers for births registered in 2016 was 31 years 19 ) were recruited. Women were eligible if they had had at least one pregnancy and self-reported no previous diagnosis of GDM. We excluded women who had been diagnosed with GDM, were unable to provide informed consent and were unable to speak or understand English. A diagnosis of GDM impacts women in rural communities disproportionately than women living in urban areas 20 ; therefore, we requested two women to be recruited from rural areas.
Once recruited, CJ participants were contacted by the research team and provided further information regarding organizational details of their attendance and informed consent documents to sign. CJ participants from urban areas were reimbursed $100 gift cards/d of the CJ. Women from rural areas were reimbursed $200/d and provided with overnight accommodation. Ethical approval was provided by the Bond University Human Research Ethics Committee (LC01914).
| Procedure
The CJ was conducted over two weekend days, 2 and 3 February 2019, at Bond University (see Table 1 for schedule). All sessions, except for the private deliberation on Sunday, were facilitated by RT (a psychologist and experienced facilitator), who moderated discussions and ensured all jurors had equal opportunity to voice opinions. Two researchers, AMS, RS and an observer from Therapeutic Guidelines, LAC, observed CJ processes and jurors' engagement for the sessions except the private deliberation. Only CJ participants were present during private deliberation to maintain confidentiality and prevent bias. Participants provided written consent prior to participating.
Four presentations were conducted on Saturday (via voice-over PowerPoint) and followed with a telephone question and answer session with each presenter (descriptions of topics and experts are provided in Box 1). After the presentations, the CJ participants completed two activities (see below) to assist in answering the two jury questions.
On Sunday, CJ participants reconvened. Following a discussion about reflections from Saturday and overnight, participants were offered the opportunity to further question presenters for additional information and clarification. CJ participants elected a representative to facilitate private deliberation and deliberated on the two CJ questions until consensus or impasse was reached. The CJ recommendations were presented to the Chair of the Steering Committee Paul Glasziou and to the researchers and observers. At the conclusion of the CJ, participants were provided opportunity to debrief on CJ processes and outcomes.
| Materials
| Presentations
Four experts provided presentations to the CJ participants.
Presenters, their topics, a short biography and their presentation URLs are provided in Box 1. Participants were provided with biographies of the presenters and copies of PowerPoint presentations. No reimbursement (financial or otherwise) was provided to the experts.
| Activity 1: Ranking the consequences of GDM
The Steering Committee identified physical and emotional consequences often reported in GDM as important for the CJ participants. To quantify the physical consequences (eg pre-term birth, caesarean section, macrosomia, shoulder dystocia), we used risk ratios identified by McIntyre et al 21 to construct icon arrays for CJ participants. We conducted a systematic review of qualitative data 22 to identify reports of emotional consequences. Twelve identified consequences were described on A4 size laminated paper and were presented and explained to the CJ participants. A further four blank consequence pages were also provided. A smaller version of each consequence and its description is provided in Supplementary File S1.
On Day 1, CJ participants individually ranked the consequences on a worksheet. The group then discussed their rankings and their reasons which were documented on a whiteboard. On day 2, the participants discussed their rankings again and deliberated in private. The descriptions were as follows:
TA B L E 1 Schedule of events
A Katie: developed diabetes as a result of pregnancy (ie this woman now met the criteria for non-pregnant diabetes);
B Jenny: has higher than usual blood sugar levels as a result of the pregnancy and is at increased risk of complications;
C Emily: has higher than usual blood sugar levels as a result of the pregnancy and is at normal risk of complications; and D Sofia: had diabetes before pregnancy and still has diabetes in pregnancy.
The risk of complications was deliberately varied in scenarios B
and C to examine its impact on the label. See Supplementary File S2 for clinical descriptions provided to the CJ participants.
Participants were given scenarios and a list of the potential labels with two blank options describing the four different clinical states.
The descriptors and the labels were developed in consultation with the Steering Committee, GPs and research colleagues.
On day 1, CJ participants were asked to identify their preferred label for each of the scenarios A-D followed by a discussion about reasons. CJ participants were asked to individually post each label to a laminated vignette which had been arranged on a wall. All labels had to be used, either with a vignette description or in a personal 'discarded' pile. Participants could also develop alternative labels.
On day 2, CJ participants deliberated in private. 
| Statistical analysis
| RE SULTS
| Jury recommendations and potential reasons
| Question 1
In the jury's view, which important consequences of a diagnosis of GDM should be considered by the consensus panel when discussing the Australian definition of GDM?
CJ recommendation
The CJ participants grouped together some of the 12 consequences identified from the systematic review as they considered this best reflected their content. For example, the consequence labelled 'burden of managing GDM' also incorporated 'dietary management-related stress' and 'increased medical appointments'.
Therefore, the list of 12 consequences was reduced to six. The women ranked the new groups of consequences that they considered the most important to women, from highest priority to lowest (see Box 2). The CJ participants concluded that:
BOX 1 Expert presentations and download links
P4: We felt collectively that the most significant consequence of being diagnosed, being told you've got a diagnosis for women was the negative emotions that go with that, the guilt and the -everything, self-blame and sadness and dread and all that, expectation and all of that. We felt collectively that that was the number one consequence.
(day 2 page 131)
The women did not identify any additional consequences to include than those synthesized from the available evidence.
Potential reasons from reflections and deliberations
At the start of day 1, the women had individually ranked the potential consequences of GDM on day 1, most women ( The women also articulated the distinction between the instinctive and emotional and more deliberative thinking processes.
P4: Well our first reaction's always an emotional one, isn't it; we don't automatically look for numbers, we au-
tomatically react emotionally.
(day 2 page 133)
The women recognized that because their views were based on evidence presented by the experts on day 1, they would likely differ from those unfamiliar with the evidence.
P2: So we are thinking from the point of view that we know all the information and that's why we're putting that 'risk to baby' down at number five… But someone who doesn't know that information, like we have, that's going to be quite high actually….
P6: That's why we're an informed community jury though, because we do know the numbers, we know that that's what makes it bump down.
(day 2 page 105)
More specifically, having learned, for example that the increase in risks that are associated with a GDM diagnosis, is small for many outcomes, led to the women to consider that a diagnosis of GDM may not be helpful-and possibly even harmful-to some pregnant women: 
| Question 2
What should Australian health practitioners call the health condition currently known as GDM?
CJ recommendation
The women's final recommendations and their reasoning for what to label the four different clinical states of GDM is described in Box 3
from most preferred to least preferred for each descriptor. The women did not identify any other potential labels for GDM than those suggested and provided by the Steering Committee and clinical and research colleagues. (day 2 page 120)
Potential reasons from reflections and deliberations
The two scenarios with higher than usual blood sugar but different risks of complications (scenarios B and C) had the most discussion and the most concern about unnecessary harms. For example, when discussing the scenario depicting raised blood sugar with normal risk (scenario C), the women deliberated: 
BOX 3 CJ participants' preferred labels to describe the differing clinical states of GDM (in descending preference)
A Katie: developed diabetes as a result of pregnancy (ie now meets non-pregnant diabetes criteria)
Gestational diabetes (most preferred)
Pregnancy induced diabetes
Diabetes in pregnancy
Diabetes due to pregnancy (least preferred) P4: We're labelling Katie because we want her to have all the information and full assistance and make sure she knows exactly what she needs to do and go to the extra appointments and all the rest of it. And we didn't know whether the outcome after her pregnancy would still be diabetes, we weren't 100 per cent sure, so we listed it this way, gestational, we thought we'd label her with gestational, pregnancy induced, diabetes in pregnancy and diabetes due to pregnancy. (day 2 page 136) B. Jenny: has higher than usual blood sugar levels as a result of the pregnancy and is at increased risk of complications
Raised blood sugar in pregnancy (most preferred)
Reduced tolerance to raised blood sugar in pregnancy 
| D ISCUSS I ON
While the participants in our pilot community jury initially agreed that the most important consequence of a GDM diagnosis (rated as highest priority) was the 'opportunity to minimize the risks to the unborn baby', after reviewing the level of risks and upon reflection, the women changed their opinions and countered the 'knee jerk'
(day 2 pg 133) reaction they believe they had on day 1. After private deliberation, the women rated the most important consequence of a diagnosis of GDM to be the negative emotional state of the mother. The priority placed on this consequence over the physical consequences preferenced by the HAPO study, 1 We strengthened our methods by standardizing expert presentations as voice-over PowerPoint to minimize presenter bias and providing hyperlinks to these in the article for transparency. A steering committee was established to develop the CJ questions, and members of this group conducted the presentations. Although a small sample, we included the voices of rural and regional women.
As the women were all from South East Queensland, Australia, women from other regions might have different responses. We also represented the evidence of consequences of GDM by developing infographics of published and aggregated data 1, 22 but recognize that women relied on this evidence to form their recommendations, and these may be different if other evidence were presented.
The adverse risk of perinatal outcomes used in the HAPO study 1 underpinned the change in blood glucose levels used to diagnose GDM in some countries, such as Australia where the definition of GDM was changed in 2014. However, this change has been contentious, as since the change, some studies have reported increasing prevalence of GDM but few improvements in health outcomes. 10, 11 Moreover, many women report emotional and financial challenges when diagnosed with GDM. 22 As a risk factor, higher levels of hyperglycaemia are associated with increases the risk of post-partum type 2 diabetes and cardiovascular disease, as well as increasing in the risk of adverse perinatal outcomes. However, the current definition of GDM in Australia is not stratified for risk and the women diagnosed with GDM (irrespective of risk) are treated similarly.
Our findings lend support to a reconsideration of GDM threshold definition in Australia and what different clinical states might be called. However, these finding should be interpreted in the context of deliberative methods and their strengths and limitations. CJs are small by design, [12] [13] [14] [15] and this has sometimes been criticized. A scoping review of public deliberative techniques in health revealed CJs were the most common technique and ranged in size from 9 to 16 people. 23 However, we had fewer participants than we anticipated, and the findings should be interpreted cautiously. We cannot claim that women's views from this CJ represent broader community views. Because we wanted to recruit the population most affected by the question of GDM definition, we recruited mothers, who are challenging to recruit as they experience many competing demands on their time. When contacted, many women could not attend the required 2 days, and some had sick children during the CJ weekend.
Recruitment limitations from this study serve as key learnings, and future CJs on GDM will be adapted to suit the demands of young families. For example, for young mothers, it may be more prudent to conduct CJs on weekdays when childcare may be more accessible or conduct the CJ over multiple days/weeks (1 day a week for 2 weeks). Despite recruitment challenges, the women who did attend produced consensus recommendations and transcripts reflecting cohesive group discussion and no dissention. However, we upheld robust CJ methods. We recruited from the population we considered most affected by the question, and the jury verdict was unanimous.
